Global Head of Evidence Generation & HTA Strategy

Takeda; Opfikon; Vor Ort; CHF 273.000 - 376.000; Vollzeit

Zusammenfassung

Takeda in Zurich, Switzerland is seeking a Head of HTA, COA, and PED to lead a global evidence generation team focused on clinical outcome assessment endpoints, patient experience data strategies, and high-quality HTA support. The role shapes method development, engages with authorities and payers, and drives early strategic decisions to differentiate Takeda assets.

You will oversee the development, validation, and execution of COA endpoints, train raters, and accelerate evidence generation to

Qualifikationen

• Fifteen or more years of experience in evidence generation, health technology assessment, clinical outcome assessment, patient experience data, or a closely related field.
• Advanced degree in a scientific, clinical, epidemiologic, quantitative, or health outcomes discipline required.
• Deep knowledge of study design, healthcare data analysis, clinical outcome assessment, health system landscaping, and the regulations and guidelines related to HTA, COA, and PED.
• Proven experience leading teams of experts and building capability in a complex and rapidly evolving global environment.
• Strong track record of working with health authorities, payers, and external organizations.
• Experience with evidence generation strategies that support global access, regulatory, and value communication needs.
• Ability to build cross-functional alignment and support timely evidence generation for launches and submissions.
• Understanding of clinical outcome assessment rater training, monitoring, and quality processes and guidelines.
• Advanced knowledge of HTA methods in a changing policy environment

Aufgaben

• Lead a team of experts focused on COA endpoint development, validation, execution, and quality control across regulatory, payer, physician, and patient needs
• Drive generation and communication of high-quality, fit-for-purpose evidence to support HTA and payer evaluations globally
• Lead strategic review of COA selection and implementation to support study execution, labeling, differentiation, payer and HTA discussions
• Train and monitor COA raters to ensure quality, consistency, and compliance
• Develop team expertise in HTA methods with focus on evolving guidelines
• Build capabilities in COA and PED to differentiate and demonstrate value
• Accelerate evidence generation processes and align with local country teams for launches and submissions
• Build external partnerships to influence methods and guidelines for evolving regulatory and access environments
• Represent Takeda in interactions with health authorities, payers, and external organizations
• Ensure strong compliance with evolving regulatory requirements
• Drive operational excellence through governance, prioritization, resources, and performance metrics
• Coach and retain a high-performing team and support succession planning

Kenntnisse

Clinical outcomes

HTA methodology

Leadership and team management

Payer engagement

Strategic evidence generation

Ausbildung

Advanced degree in health outcomes/clinical research

Jobbeschreibung

Takeda in Zurich, Switzerland is seeking a Head of HTA, COA, and PED to lead a global evidence generation team focused on clinical outcome assessment endpoints, patient experience data strategies, and high-quality HTA support. The role shapes method development, engages with authorities and payers, and drives early strategic decisions to differentiate Takeda assets.

You will oversee the development, validation, and execution of COA endpoints, train raters, and accelerate evidence generation to